Literature DB >> 23809245

Advanced precancerous lesions in the liver.

Luca Di Tommaso1, Angelo Sangiovanni, Mauro Borzio, Young Nyun Park, Fabio Farinati, Massimo Roncalli.   

Abstract

We will focus on precursors of the most common liver cancer, i.e. hepatocellular carcinoma (HCC), which takes place in 90% of cases in a hepatitis/cirrhotic setting. High grade dysplastic nodules (HG-DN) are small sizable nodules and the most advanced precancerous lesions of the liver, with a risk of malignant transformation of about 30-40% at 24 months. We will survey the diagnostic distinction between them and early HCC from a clinical, radiological and pathological point of view. The use of a diagnostic algorithm supported by international guidelines is the best practice to manage HG-DN and early HCC. There is no typical imaging for HG-DN, needing all of them to be biopsied for characterization. The natural history of HG-DN is not predictable in individual cases and additional markers should be validated to increase the diagnostic accuracy and predict the behaviour. The treatment of HG-DN is under investigation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23809245     DOI: 10.1016/j.bpg.2013.03.015

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  15 in total

Review 1.  STAT3 in hepatocellular carcinoma: new perspectives.

Authors:  Jasmin Svinka; Wolfgang Mikulits; Robert Eferl
Journal:  Hepat Oncol       Date:  2013-12-20

2.  Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Zhang Zhao; Guang-Yong Chen; Jiang Long; Hai Li; Jian Huang
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

Review 3.  Benign liver tumours: understanding molecular physiology to adapt clinical management.

Authors:  Jean-Charles Nault; Valérie Paradis; Maxime Ronot; Jessica Zucman-Rossi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-14       Impact factor: 73.082

Review 4.  Latest developments in precancerous lesions of hepatocellular carcinoma.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang; Jing Zhao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 5.  Tumour evolution in hepatocellular carcinoma.

Authors:  Amanda J Craig; Johann von Felden; Teresa Garcia-Lezana; Samantha Sarcognato; Augusto Villanueva
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-02       Impact factor: 46.802

6.  Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model.

Authors:  Kun Chen; Zhiyuan Wu; Mengya Zang; Ce Wang; Yanmei Wang; Dongmei Wang; Yifan Ma; Chunfeng Qu
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 7.  The role of telomeres and telomerase in cirrhosis and liver cancer.

Authors:  Jean-Charles Nault; Massih Ningarhari; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-06-28       Impact factor: 46.802

Review 8.  Hepatocellular carcinoma: a clinical and pathological overview.

Authors:  Salvatore Lorenzo Renne; Samantha Sarcognato; Diana Sacchi; Maria Guido; Massimo Roncalli; Luigi Terracciano; Luca Di Tommaso
Journal:  Pathologica       Date:  2021-06

9.  Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.

Authors:  Ruo-Kun Li; Suzanne L Palmer; Meng-Su Zeng; Jin-Wei Qiang; Frank Chen; Sheng-Xiang Rao; Ling-Li Chen; Yong-Ming Dai
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

10.  The stromal morphological changes for differential diagnosis of uninodular high-grade dysplastic nodule and well-differentiated small hepatocellular carcinoma.

Authors:  Long-Hai Feng; Han Wang; Hui Dong; Yu-Yao Zhu; Wen-Ming Cong
Journal:  Oncotarget       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.